The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
J Clin Microbiol. 2013 Nov;51(11):3579-84. doi: 10.1128/JCM.01224-13. Epub 2013 Aug 21.
Assays that expedite the reporting of organism identification and antibiotic susceptibility status in positive blood cultures can fast track interventions that improve clinical outcomes. We evaluated the Verigene Gram-positive blood culture nucleic acid test (BC-GP) in two pediatric hospitals. Positive BacT/Alert Pediatric FAN blood cultures with Gram-positive organisms were tested using the BC-GP in tandem with routine laboratory procedures. To test organisms underrepresented in the clinical blood culture evaluation, blood culture bottles were spiked with diluted organism suspensions at concentrations of 10 to 100 CFU per milliliter. A total of 249 Gram-positive bacterial isolates were recovered from 242 blood cultures. The BC-GP detected Staphylococcus aureus, methicillin-susceptible S. aureus, and methicillin-resistant S. aureus with sensitivities of 100%, 99%, and 100% and specificities of 100%, 100%, and 99.5%, respectively. The BC-GP detected Staphylococcus epidermidis, methicillin-susceptible S. epidermidis, and methicillin-resistant S. epidermidis with sensitivities of 95%, 80%, and 96%, respectively, and 100% specificity. The BC-GP correctly identified 14/15 cases of Enterococcus faecalis and Enterococcus faecium bacteremia and 9 cases of Streptococcus pneumoniae. It misidentified 5/15 clinical blood cultures with Streptococcus mitis/Streptococcus oralis and 1/3 blood cultures spiked with Streptococcus anginosus group as S. pneumoniae. The BC-GP detected a case of Streptococcus pyogenes bacteremia but failed to detect 2/3 clinical blood cultures with Streptococcus agalactiae. BC-GP's rapid accurate detection of Staphylococcus spp., E. faecium, and E. faecalis and its ability to ascertain mecA, vanA, and vanB status may expedite clinical decisions pertaining to optimal antibiotic use. False-positive S. pneumoniae results may warrant reporting of only "Streptococcus spp." when this organism is reported by the BC-GP.
快速报告阳性血培养物中微生物鉴定和抗生素药敏状态的检测方法可以快速采取干预措施,改善临床结果。我们在两家儿童医院评估了 Verigene 革兰阳性血培养核酸检测(BC-GP)。使用 BC-GP 与常规实验室程序一起检测阳性 BacT/Alert Pediatric FAN 革兰阳性菌血培养物。为了检测临床血培养评估中代表性不足的微生物,将稀释的微生物混悬液以每毫升 10 到 100 CFU 的浓度加入血培养瓶中。从 242 份血培养物中总共回收了 249 株革兰阳性细菌分离株。BC-GP 检测金黄色葡萄球菌、甲氧西林敏感金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的敏感性分别为 100%、99%和 100%,特异性分别为 100%、100%和 99.5%。BC-GP 检测表皮葡萄球菌、甲氧西林敏感表皮葡萄球菌和耐甲氧西林表皮葡萄球菌的敏感性分别为 95%、80%和 96%,特异性均为 100%。BC-GP 正确鉴定了 14/15 例粪肠球菌和屎肠球菌菌血症和 9 例肺炎链球菌菌血症。它错误地鉴定了 5/15 例链球菌/口腔链球菌和 1/3 例链球菌组咽峡炎血培养物为肺炎链球菌。BC-GP 检测到 1 例化脓性链球菌菌血症,但未能检测到 2/3 例无乳链球菌血培养物。BC-GP 快速准确地检测到金黄色葡萄球菌、屎肠球菌和粪肠球菌,并能够确定 mecA、vanA 和 vanB 状态,这可能会加快与最佳抗生素使用相关的临床决策。假阳性肺炎链球菌结果可能需要仅报告“链球菌属”,当 BC-GP 报告该微生物时。